Literature DB >> 16896823

Elevated procalcitonin as a diagnostic marker in meningococcal disease.

G D Mills1, H M Lala, M R Oehley, A B Craig, K Barratt, D Hood, C N Thornley, A Nesdale, N E Manikkam, P Reeve.   

Abstract

Patients with meningococcal disease who seek medical attention can create a diagnostic dilemma for clinicians due to the nonspecific nature of the disease's presentation. This study assesses the diagnostic accuracy of procalcitonin levels in the setting of meningococcal disease. Two emergency department cohorts (A and B) were studied between 2002 and 2005, during the current epidemic of serogroup B meningococcal disease in New Zealand. Cohort A consisted of 171 patients, all with confirmed meningococcal disease (84 children, 87 adults). Cohort B consisted of a large (n=1,524) consecutively recruited population of febrile patients who presented to the emergency department, 28 of whom had confirmed meningococcal disease. Within the meningococcal disease cohort (cohort A), the geometric mean procalcitonin level was 9.9 ng/ml, with levels being higher in children than in adults (21.6 vs. 4.6 ng/ml, p=0.01). The overall sensitivity of elevated procalcitonin, using a cutoff of 2.0 ng/ml in children and 0.5 ng/ml in adults, was 0.93 (95%CI: 0.88-0.96). Despite the higher cutoff level for paediatric patients, a trend towards greater sensitivity existed in children (0.96 vs. 0.90; p=0.08). Elevated procalcitonin was correlated with whole blood meningococcal load (r=0.50) and Glasgow Meningococcal Sepsis Prognostic Score (r=0.40). Within the cohort of patients who were febrile on presentation (cohort B), the specificity of elevated procalcitonin in meningococcal disease was 0.85 (95% CI: 0.83-0.87), the positive and negative likelihood ratios were 6.1 and 0.08, respectively, and the sensitivity of elevated procalcitonin (0.93; 95% CI: 0.76-0.99) was corroborated. Measurement of procalcitonin is a useful tool in patients with nonspecific febrile illnesses when the possibility of meningococcal disease is present. The diagnostic accuracy surpasses that of current early laboratory markers, allowing results to be used to guide decisions about patient management.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896823     DOI: 10.1007/s10096-006-0179-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  28 in total

1.  Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

Authors:  Mirjam Christ-Crain; Daiana Jaccard-Stolz; Roland Bingisser; Mikael M Gencay; Peter R Huber; Michael Tamm; Beat Müller
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

2.  Meningococcal septic shock in children: clinical and laboratory features, outcome, and development of a prognostic score.

Authors:  R F Kornelisse; J A Hazelzet; W C Hop; L Spanjaard; M H Suur; E van der Voort; R de Groot
Journal:  Clin Infect Dis       Date:  1997-09       Impact factor: 9.079

3.  High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis.

Authors:  A Viallon; F Zeni; C Lambert; B Pozzetto; B Tardy; C Venet; J C Bertrand
Journal:  Clin Infect Dis       Date:  1999-06       Impact factor: 9.079

4.  Kinetics of procalcitonin in iatrogenic sepsis.

Authors:  F M Brunkhorst; U Heinz; Z F Forycki
Journal:  Intensive Care Med       Date:  1998-08       Impact factor: 17.440

5.  Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-alpha and interleukin-6 in patients with sepsis.

Authors:  M Oberhoffer; W Karzai; A Meier-Hellmann; D Bögel; J Fassbinder; K Reinhart
Journal:  Crit Care Med       Date:  1999-09       Impact factor: 7.598

6.  Unsuspected meningococcemia.

Authors:  B Dashefsky; D W Teele; J O Klein
Journal:  J Pediatr       Date:  1983-01       Impact factor: 4.406

7.  Meningococcal disease: a comparison of eight severity scores in 125 children.

Authors:  H H Derkx; J van den Hoek; W K Redekop; R P Bijlmer; S J van Deventer; P M Bossuyt
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

Review 8.  Procalcitonin as an early marker of infection in neonates and children.

Authors:  A M C van Rossum; R W Wulkan; A M Oudesluys-Murphy
Journal:  Lancet Infect Dis       Date:  2004-10       Impact factor: 25.071

9.  Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count.

Authors:  Juan Casado-Flores; Alfredo Blanco-Quirós; Julia Asensio; Eduardo Arranz; Jose A Garrote; Monserrat Nieto
Journal:  Pediatr Crit Care Med       Date:  2003-04       Impact factor: 3.624

10.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

View more
  7 in total

1.  Evaluation of potential biomarkers for the discrimination of bacterial and viral infections.

Authors:  P Chalupa; O Beran; H Herwald; N Kaspříková; M Holub
Journal:  Infection       Date:  2011-07-01       Impact factor: 3.553

2.  Can Procalcitonin in Cerebrospinal Fluid be a Diagnostic Tool for Meningitis?

Authors:  Theocharis Konstantinidis; Dimitrios Cassimos; Theodora Gioka; Christina Tsigalou; Theodoros Parasidis; Ioanna Alexandropoulou; Christos Nikolaidis; Georgia Kampouromiti; Theodoros Constantinidis; Athanasios Chatzimichael; Maria Panopoulou
Journal:  J Clin Lab Anal       Date:  2014-05-05       Impact factor: 2.352

3.  Serum procalcitonin in viral and bacterial meningitis.

Authors:  Usama M Alkholi; Nermin Abd Al-Monem; Ayman A Abd El-Azim; Mohamed H Sultan
Journal:  J Glob Infect Dis       Date:  2011-01

4.  Clinical and Cost-Effectiveness of Procalcitonin Test for Prodromal Meningococcal Disease-A Meta-Analysis.

Authors:  Jennifer M Bell; Michael D Shields; Ashley Agus; Kathryn Dunlop; Thomas Bourke; Frank Kee; Fiona Lynn
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

5.  Dynamic changes and diagnostic and prognostic significance of serum PCT, hs-CRP and s-100 protein in central nervous system infection.

Authors:  Jiaan Wang; Xicai Wu; Yufeng Tian; Xueyuan Li; Xia Zhao; Min Zhang
Journal:  Exp Ther Med       Date:  2018-10-16       Impact factor: 2.447

6.  Serum procalcitonin in bacterial & non-bacterial meningitis in children.

Authors:  Shipra Chaudhary; Nisha Keshary Bhatta; Madhab Lamsal; Rajendra Kumar Chaudhari; Basudha Khanal
Journal:  BMC Pediatr       Date:  2018-11-02       Impact factor: 2.125

Review 7.  A 2020 review on the role of procalcitonin in different clinical settings: an update conducted with the tools of the Evidence Based Laboratory Medicine.

Authors:  Anna Maria Azzini; Romolo Marco Dorizzi; Piersandro Sette; Marta Vecchi; Ilaria Coledan; Elda Righi; Evelina Tacconelli
Journal:  Ann Transl Med       Date:  2020-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.